In MM, osteoclast activity is abnormally increased due to cytokines (e.g., interleukin (IL)-6, IL-1, and IL-17) produced by interactions between myeloma cells and the bone marrow [13]. This evidence concerns the gene IL17A and plasma cell myeloma.